CDC-9 Inactivated Rotavirus Vaccine (IRV) Intramuscular (IM) Phase 1 Clinical Trial in Healthy Adults

NCT06485258 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

FED

Sponsor class

Conditions

Rotavirus Infections

Interventions

BIOLOGICAL: 3.75 µg Dose of CDC-9 Inactivated Rotavirus Vaccine (IRV)
BIOLOGICAL: 7.5 µg Dose of CDC-9 Inactivated Rotavirus Vaccine (IRV)
OTHER: Placebo

Sponsor

Centers for Disease Control and Prevention

Collaborators

[object Object]
[object Object]
[object Object]